PharmEasy IPO Details: Everything You Should Know about 

Click Here and Sign Up to Get Experts’ Verdicts on PharmEasy IPO

The IPO opening date for the PharmEasy IPO has not been announced yet, but the company has already filed its DRHP with SEBI/Exchange on 9th November 2021, and SEBI approval was received on 17th February 2025. It is a bookbuilding IPO of  ₹6,250 crore shares. The issue will be listed on NSE and BSE, and the tentative date is yet to be announced.

PharmEasy IPO Details

The PharmEasy IPO date is not fixed yet. The face value of PharmEasy shares stands at ₹2 per share, and the IPO price band is fixed at [.] to [.] per share.

Kfin Technologies Limited is the registrar of PharmEasy IPO and is responsible for managing the allotment process and initiating refunds. Check out the latest IPO details in the table below.

PharmEasy IPO Details 

PharmEasy IPO GMP 

Note: PharmEasy is yet to open. We will update the PharmEasy GMP data post an official announcement.

PharmEasy IPO DRHP Status

PharmEasy IPO Review

Check out the detailed PharmEasy IPO review for a thorough understanding of its potential to report listing gains. The PharmEasy IPO review will help you invest effectively to avoid significant losses. Explore more to make an informed Investment decision on this IPO.

Financial Health

Assess a company’s financial performance to know about its ability to sustain a competitive edge. Therefore, it is crucial to comprehend the business’s financial growth margins and declines before applying for the PharmEasy IPO.

PharmEasy Limited’s revenue increased by 365.039% from ₹6410 crores in March 2020 to ₹29,809 crores in March 2021. Moreover, the company’s PAT increased by 91.33% from ₹3350 crores to ₹6,410 crores. Investors can analyse other relevant factors and make a decision accordingly.

PharmEasy Limited’s IPO has shown consistent revenue growth, indicating that the company is financially stable. Moreover, the brokers, investors, and RAs have a positive outlook for Milky Mist Dairy Foods’ IPO for its tentative listing day.

Technical Analysis

Some technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the PharmEasy IPO

The PE ratio of PharmEasy Limited’s share is [.], and its Earnings Per Share (EPS) stands at [.]. Thus, the IPO of PharmEasy Limited can deliver gains on its tentative listing day.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of PharmEasy Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics. 

About the PharmEasy Limited Company Overview

Pharmeasy is India’s leading online healthcare platform that provides medicines diagnostic, and healthcare products at doorsteps. The company’s main aim is to provide accessible ,affordable healthcare and to make it convenient for people. By the pharmEasy app and through their website people can book lab tests and buy health related products. The company has a strong presence in all over India; they have partnerships with doctors, diagnostic labs and pharmacies through which a large ecosystem is created. PharmEasy is mainly known for its Tech driven approach, user friendly app and to provide a wide range of services.

PharmEasy Limited Financials

The company’s financial analysis is essential before applying for the IPO of PharmEasy Limited. Look at the table to learn about PharmEasy Limited’s financials. 

Explanation

PharmEasy Limited’s revenue increased by 365.039% from ₹6410 crores in March 2020 to ₹29,809 crores in March 2021. Moreover, the company’s PAT increased by 91.33% from ₹3350 crores to ₹6,410 crores. Investors can analyse other relevant factors and make a decision accordingly.

PharmEasy IPO Promoter Holdings

Have a look at the table below to check the holdings of PharmEasy Limited’s promoters: 

Note: The value will be calculated using Equity Dilution = Share Holding Pre-Issue –  Share Holding Post-Issue.

PharmEasy IPO Objectives

The primary aim of PharmEasy is to raise ₹2,035 crores. On the other hand, PharmEasy has decided to utilise these funds in different ways.

Should I Invest in PharmEasy IPO?

Explore the pros and cons of PharmEasy IPO to know whether you should apply or avoid the issue. These pros and cons might help you understand the IPO’s efficiency in delivering profits in the coming decades.

Pros of PharmEasy IPO

• PharmEasy has the highest brand recall and it is India’s top online healthcare brand.
• PharmEasy offers wide variety of services like Medicines, Diagnostics, and healthcare products at a single platform
• The company has a strong service delivery in more than 1000 cities and has strong coverage.
• PharmaEasy adopts a tech driven model that offers user friendly apps, AI based recommendation and order management.
• After covid 19 online medicines and e health there is a rise in demand for Indian healthcare.

Cons of PharmEasy IPO

• PharmEasy faces high intense competition from Tata 1mg, Apollo 24/7
• There is a compliance risk in the online pharmacy sector.
• Highly dependent on customers to get engagement in online pharmacy platforms.
• High chances of data privacy risk
• To maintain pan india delivery and cold medicines is costly and challenging.

How to Invest in the PharmEasy IPO?

PharmEasy has not opened yet. And most investors are still waiting for it. Here is how you will be able to invest in PharmEasy IPO after its opening. 

• Open a demat account or use your existing demat account to make a bid. 
• Navigate to the PharmEasy section to make an application.
• Select the number of lots you want to apply for and proceed with your application further. 
• Once you have applied for the PharmEasy  IPO, you will receive a mandate request on the selected mode of transaction.
• Approve the mandate request and get your application number instantly. 

How to Check PharmEasy IPO Allotment Status?

You can check for the PharmEasy IPO allotment in different ways. These include NSE and the registrar portal. Look at the steps mentioned below to check your allotment status online.

Check On NSE

• Visit the NSE Official Website.
• Navigate to the IPO Allotment Section. 
• Select Equity as the issue type. 
• Choose the PharmEasy IPO.  
• Choose whether to proceed with the PAN number or the application number.
• Submit your details to get the allotment status online. 

Check On the Registrar Portal

• Visit the registrar portal. 
• Click on the allotment option.
• Fill in the required details.
• Click on the submit button to know your PharmEasy allotment status.

Final Thoughts

PharmEasy is now again gathering investors’ attention with a positive note to be announced officially in July 2025. Kfin Technologies Limited has recently filed for PharmEasy worth ₹6,250 crores with SEBI via a confidential route. The issue is subject to the approval of SEBI. Investors are cautious about PharmEasy IPO details, such as issue date, price band, lot size, subscription, and other key information.

Stay informed with Univest to get regular updates on the PharmEasy  IPO, GMP, subscription, and more!

 FAQs on PharmEasy IPO

When did PharmEasy file IPO draft papers?

Ans. PharmEasy filed its updated draft papers with SEBI for an IPO of up to ₹6,250 crore shares on 9th November 2021.

What are the uses of IPO proceeds?

Ans. PharmEasy has raised funds through its IPO to expand its business operations. 

Is PharmEasy a publicly listed company?

Ans. PharmEasy is listed on stock exchanges, so it is a publicly listed company. PharmEasy had gone public through an IPO filing of ₹6250 crore shares.

What is the issue size for Mist Dairy Foods?

Ans. It is a bookbuilding IPO comprising a fresh issue and offer for sale to raise approximately ₹6,250 crore shares. 

Is PharmEasy good?

Ans:  PharmEasy Limited’s revenue increased by 365.039% from ₹6410 crores in March 2020 to ₹29,809 crores in March 2021. Moreover, the company’s PAT increased by 91.33% from ₹3350 crores to ₹6,410 crores. Investors can analyse other relevant factors and make a decision accordingly..Investors can analyse other relevant factors and make a decision accordingly.

Who will be the registrar of the PharmEasy IPO?

Ans. As per the recent updates,MUFG India Intime Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding PharmEasy GMP, allotment, and refund, you can contact MUFG India Intime Private Limited

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To obtain detailed information about the PharmEasy IPO, please wait for the RHP and DRHP to be released by Milky Mist Dairy Foods. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.

Upcoming IPOs

Current & Previous IPOs

Read Our Articles on the Best Stocks

Tech Stocks in India to Invest in 2025 | Tech Sector Stocks 

Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks 

Best Shipping Stocks in India to Invest in 2025 | Shipping Sector Stocks 

Paint Stocks in India to Invest in 2025 | Paint Sector Stocks 

Paper Stocks in India to Invest in 2025 | Paper Sector Stocks 

Best Semiconductor Stocks in India 2025 

Best Large Cap Stocks in India 2025 

Green Energy Penny Stocks

Best Cement Stocks To Invest in India

Also Explore

Univest Screeners